The strong negative correlation between IL17RA and immature B cells suggests that targeting IL17RA or the IL-17 signaling pathway may aid in restoring immature B cell numbers and function, potentially alleviating MDD symptoms. This evidence concerns the gene IL17A and major depressive disorder.